| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Departments of 1 Cell and Molecular Biology and 2 Pathology; 3 Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; 4 Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada; and 5 College of Pharmacy, University of New Mexico, Albuquerque, New Mexico
Requests for reprints: M. Sharon Stack, Department of Cell and Molecular Biology, Northwestern University, 303 East Chicago Avenue, Tarry 8-715, Chicago, IL 60611. Phone: 312-908-8216; Fax: 312-503-7912; E-mail: mss130{at}northwestern.edu.
Elevated levels of the bioactive lipid lysophosphatidic acid (LPA) are detectable in the majority of patients with both early- and late-stage ovarian cancer, suggesting that LPA promotes early events in ovarian carcinoma dissemination. LPA contributes to the development, progression, and metastasis of ovarian cancer in part by inducing the expression of genes that contribute to proliferation, survival, or invasion, including cyclooxgenase-2 (COX-2) and matrix metalloproteinase–2 (MMP-2). We have previously shown that LPA promotes proMMP-2 activation and MMP-2–dependent migration and invasion in ovarian cancer cells. The purpose of the current study was to determine whether the effect of LPA on acquisition of the metastatic phenotype in ovarian cancer cells is mediated via a COX-2–dependent mechanism. Immunohistochemical analysis of 173 ovarian tumors showed strong COX-2 immunoreactivity in 63% of tumor specimens, including 50% of borderline tumors. LPA increased COX-2 protein expression in a time- and concentration-dependent manner in two of three immortalized borderline ovarian epithelial cells as well as in four of six ovarian cancer cell lines. This was accomplished by both activation of the Edg/LPA receptor and LPA-mediated transactivation of the epidermal growth factor receptor, which increased COX-2 expression via the Ras/mitogen-activated protein kinase pathway. COX-2 also played a role in LPA-induced invasion and migration, as treatment with the COX-2 specific inhibitor NS-398 reduced LPA-induced proMMP-2 protein expression and activation and blocked MMP-dependent motility and invasive activity. These data show that COX-2 functions as a downstream mediator of LPA to potentiate aggressive cellular behavior.
Key Words: Ovarian cancer • Cyclooxgenase-2 • Lysophosphatidic acid • Matrix metalloproteinase
This article has been cited by other articles:
|
|
 |
|
  I. Woclawek-Potocka, K. Kondraciuk, and D. J. Skarzynski Lysophosphatidic Acid Stimulates Prostaglandin E2 Production in Cultured Stromal Endometrial Cells Through LPA1 Receptor Experimental Biology and Medicine, August 1, 2009; 234(8): 986 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, D. Wang, H. Zhang, K. Kirmani, Z. Zhao, R. Steinmetz, and Y. Xu Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice Mol. Cancer Ther., June 1, 2009; 8(6): 1692 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kalari, Y. Zhao, E. Wm. Spannhake, E. V. Berdyshev, and V. Natarajan Role of acylglycerol kinase in LPA-induced IL-8 secretion and transactivation of epidermal growth factor-receptor in human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L328 - L336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Song, J. Wu, R. A. Oyesanya, Z. Lee, A. Mukherjee, and X. Fang Sp-1 and c-Myc Mediate Lysophosphatidic Acid-Induced Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Cells via a Hypoxia-Inducible Factor-1-Independent Mechanism Clin. Cancer Res., January 15, 2009; 15(2): 492 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Liszewska, P. Reinaud, E. Billon-Denis, O. Dubois, P. Robin, and G. Charpigny Lysophosphatidic Acid Signaling during Embryo Development in Sheep: Involvement in Prostaglandin Synthesis Endocrinology, January 1, 2009; 150(1): 422 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Seo, M. Kim, Y. Choi, C.-K. Lee, and H. Ka Analysis of Lysophosphatidic Acid (LPA) Receptor and LPA-Induced Endometrial Prostaglandin-Endoperoxide Synthase 2 Expression in the Porcine Uterus Endocrinology, December 1, 2008; 149(12): 6166 - 6175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yu, M. M. Murph, Y. Lu, S. Liu, H. S. Hall, J. Liu, C. Stephens, X. Fang, and G. B. Mills Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer Cells J Natl Cancer Inst, November 19, 2008; 100(22): 1630 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ye Lysophospholipid signaling in the function and pathology of the reproductive system Hum. Reprod. Update, September 1, 2008; 14(5): 519 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Oyesanya, Z. P. Lee, J. Wu, J. Chen, Y. Song, A. Mukherjee, P. Dent, T. Kordula, H. Zhou, and X. Fang Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells FASEB J, August 1, 2008; 22(8): 2639 - 2651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aponte, W. Jiang, M. Lakkis, M.-J. Li, D. Edwards, L. Albitar, A. Vitonis, S. C. Mok, D. W. Cramer, and B. Ye Activation of Platelet-Activating Factor Receptor and Pleiotropic Effects on Tyrosine Phospho-EGFR/Src/FAK/Paxillin in Ovarian Cancer Cancer Res., July 15, 2008; 68(14): 5839 - 5848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wang, Z. Zhao, A. Caperell-Grant, G. Yang, S. C. Mok, J. Liu, R. M. Bigsby, and Y. Xu S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells Mol. Cancer Ther., July 1, 2008; 7(7): 1993 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhao, M. Goswami, N. Pokhriyal, H. Ma, H. Du, J. Yao, T. A. Victor, K. Polyak, C. D. Sturgis, H. Band, et al. Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression Cancer Res., January 15, 2008; 68(2): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Said, M. J. Socha, J. J. Olearczyk, A. A. Elmarakby, J. D. Imig, and K. Motamed Normalization of the Ovarian Cancer Microenvironment by SPARC Mol. Cancer Res., October 1, 2007; 5(10): 1015 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Symowicz, B. P. Adley, K. J. Gleason, J. J. Johnson, S. Ghosh, D. A. Fishman, L. G. Hudson, and M. S. Stack Engagement of Collagen-Binding Integrins Promotes Matrix Metalloproteinase-9-Dependent E-Cadherin Ectodomain Shedding in Ovarian Carcinoma Cells Cancer Res., March 1, 2007; 67(5): 2030 - 2039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-q. Wang, Y. Smicun, N. Calluzzo, and D. A. Fishman Inhibition of Matrilysin Expression by Antisense or RNA Interference Decreases Lysophosphatidic Acid-Induced Epithelial Ovarian Cancer Invasion Mol. Cancer Res., November 1, 2006; 4(11): 831 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Mrena, J-P Wiksten, S Nordling, A Kokkola, A Ristimaki, and C Haglund MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J. Clin. Pathol., June 1, 2006; 59(6): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ren, Y.-j. Xiao, L. S. Singh, X. Zhao, Z. Zhao, L. Feng, T. M. Rose, G. D. Prestwich, and Y. Xu Lysophosphatidic Acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res., March 15, 2006; 66(6): 3006 - 3014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Lee, R. F. Swaby, Y. Liang, S. Yu, S. Liu, K. H. Lu, R. C. Bast Jr., G. B. Mills, and X. Fang Lysophosphatidic Acid Is a Major Regulator of Growth-Regulated Oncogene {alpha} in Ovarian Cancer. Cancer Res., March 1, 2006; 66(5): 2740 - 2748. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
